Luma Group

Luma Group is a New York-based investment firm specializing in technology-driven investments within the life sciences, healthcare, and biotech sectors. Their mission is to advance human health outcomes across the United States by supporting innovative companies in these fields. The firm manages assets totaling approximately $66 million, as reported in their SEC filings.

The firm's investment strategy encompasses a wide range of stages, including Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, and Distressed investments. This approach allows Luma Group to provide flexible capital solutions tailored to the unique needs of each portfolio company. Their focus on both venture capital and private equity enables them to support companies at various stages of development, from early-stage startups to more established enterprises seeking growth capital.

Luma Group's portfolio includes a diverse array of companies across the technology, life sciences, healthcare, and biotech industries. While specific portfolio companies are not publicly disclosed, the firm's broad industry focus reflects its commitment to fostering innovation and improving human health outcomes. Their investment philosophy emphasizes a disciplined and patient approach, seeking opportunities that align with their strategic vision and offer the potential for significant impact in the healthcare sector.